Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1) — Stella

Recruiting

Back to Schizophrenia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

The University of Texas Health Science Center, Houston, Houston, Texas

Key details

Sponsor

The University of Texas Health Science Center, Houston

Enrollment target

~120 participants

Started

May 2024

Primary completion

May 2029

Age range

18 Years – 60 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov